Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

EMIG

- PMLiVE

Blackwood returns as new life sciences minister

Replaces James O’Shaughnessy at DHSC

- PMLiVE

Time running out for ‘no-deal’ Brexit medicines laws

Needs parliament clearance before 29 March

Bear and Two Foxes

Givers and Takers

Have we lost the ability to identify the difference between net givers and net takers of energy?

Page & Page and Partners

Q&A with Dr Timothy Vollmer, leading MS Neurologist

Blue Latitude Health sits down with key opinion leader and specialist neurologist Dr Timothy Vollmer to better understand the paradigm shift in MS treatment. He explains the challenges neurologists face...

Blue Latitude Health

- PMLiVE

Pharma’s confidence in Brexit deal falls as vote looms

Most EMIG members have little or no confidence in the government’s abilities to obtain a good deal

- PMLiVE

Post-Brexit immigration policy has a critical missing piece

ABPI welcomes focus on skills, but UK must respond fast to skills gaps

- PMLiVE

Business warning as talk of Brexit ‘No deal’ grows

'Managed no deal' plan is 'not a credible position' warns business

- PMLiVE

D-day: time to make digital deliver

Chris Ross looks at why a platform-based, outcomes-focused approach could be key to demonstrating the value of digital health solutions

- PMLiVE

Brexit contributes to surge in generic drug prices

Calls for government to protect pharmacies

- PMLiVE

‘No deal’ Brexit could see pharmacists take lead amid drug shortages

Government steps up preparations as Brexit day nears

- PMLiVE

As May delays, industry warns again of ‘no-deal’ Brexit

Brussels offers warm words, but no renegotiation

- PMLiVE

Industry frustrated by late warning on ‘no deal’ Brexit disruption

Dover and Folkestone could have 6 months of disruption

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links